A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 15082617.
- Also identified by PMC identifier 1867781.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Symptoms are an important outcome for measurement in clinical trials into gastro-oesophageal reflux disease, but the optimal approach to symptom assessment has not been formally evaluated. The authors conducted a systematic review to assess how reflux symptoms have been evaluated and how well these correlate with oesophagitis healing and relapse.
Medical subject headings
- Esophagitis
- Gastroesophageal Reflux